BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 36757708)

  • 21. Anaplastic thyroid carcinoma: changing trends of treatment strategies and associated overall survival.
    Wächter S; Vorländer C; Schabram J; Mintziras I; Fülber I; Manoharan J; Holzer K; Bartsch DK; Maurer E
    Eur Arch Otorhinolaryngol; 2020 May; 277(5):1507-1514. PubMed ID: 32060602
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Complete Surgical Resection Following Neoadjuvant Dabrafenib Plus Trametinib in
    Wang JR; Zafereo ME; Dadu R; Ferrarotto R; Busaidy NL; Lu C; Ahmed S; Gule-Monroe MK; Williams MD; Sturgis EM; Goepfert RP; Gross ND; Lai SY; Gunn GB; Phan J; Rosenthal DI; Fuller CD; Morrison WH; Iyer P; Cabanillas ME
    Thyroid; 2019 Aug; 29(8):1036-1043. PubMed ID: 31319771
    [No Abstract]   [Full Text] [Related]  

  • 23. Survival in Response to Multimodal Therapy in Anaplastic Thyroid Cancer.
    Prasongsook N; Kumar A; Chintakuntlawar AV; Foote RL; Kasperbauer J; Molina J; Garces Y; Ma D; Wittich MAN; Rubin J; Richardson R; Morris J; Hay I; Fatourechi V; McIver B; Ryder M; Thompson G; Grant C; Richards M; Sebo TJ; Rivera M; Suman V; Jenkins SM; Smallridge RC; Bible KC
    J Clin Endocrinol Metab; 2017 Dec; 102(12):4506-4514. PubMed ID: 29029287
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Surgery After BRAF-Directed Therapy Is Associated with Improved Survival in BRAF
    Zhao X; Wang JR; Dadu R; Busaidy NL; Xu L; Learned KO; Chasen NN; Vu T; Maniakas A; Eguia AA; Diersing J; Gross ND; Goepfert R; Lai SY; Hofmann MC; Ferrarotto R; Lu C; Gunn GB; Spiotto MT; Subbiah V; Williams MD; Cabanillas ME; Zafereo ME
    Thyroid; 2023 Apr; 33(4):484-491. PubMed ID: 36762947
    [No Abstract]   [Full Text] [Related]  

  • 25. Completely resected anaplastic thyroid carcinoma combined with adjuvant chemotherapy and irradiation is associated with prolonged survival.
    Haigh PI; Ituarte PH; Wu HS; Treseler PA; Posner MD; Quivey JM; Duh QY; Clark OH
    Cancer; 2001 Jun; 91(12):2335-42. PubMed ID: 11413523
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Survival and prognostic factors of anaplastic thyroid carcinoma.
    Paunovic IR; Sipetic SB; Zoric GV; Diklic AD; Savic DV; Marinkovic J; Zivaljevic VR
    Acta Chir Belg; 2015; 115():62-7. PubMed ID: 26021793
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Surgery combined with adjuvant radiation and chemotherapy prolonged overall survival in stage IVC anaplastic thyroid cancer: a SEER-based analysis.
    Yin Y; Wang L; Huang C
    Endocrine; 2024 Jan; ():. PubMed ID: 38183567
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optimal combination of treatment modality to increase survival in patients with anaplastic thyroid carcinoma: A STROBE compliant retrospective study.
    Lee JH; Ahn HK; Seok JY; Lee KC; Chun YS; Chung YS; Lee YD
    Medicine (Baltimore); 2018 Jun; 97(25):e11037. PubMed ID: 29923991
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Salvage Lenvatinib Therapy in Metastatic Anaplastic Thyroid Cancer.
    Iñiguez-Ariza NM; Ryder MM; Hilger CR; Bible KC
    Thyroid; 2017 Jul; 27(7):923-927. PubMed ID: 28471306
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Facilitating anaplastic thyroid cancer specialized treatment: A model for improving access to multidisciplinary care for patients with anaplastic thyroid cancer.
    Cabanillas ME; Williams MD; Gunn GB; Weitzman SP; Burke L; Busaidy NL; Ying AK; Yiin YH; William WN; Lu C; Lai SY
    Head Neck; 2017 Jul; 39(7):1291-1295. PubMed ID: 28452157
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment outcomes in anaplastic thyroid carcinoma: survival improvement in young patients with localized disease treated by combination of surgery and radiotherapy.
    Yau T; Lo CY; Epstein RJ; Lam AK; Wan KY; Lang BH
    Ann Surg Oncol; 2008 Sep; 15(9):2500-5. PubMed ID: 18581185
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anaplastic thyroid cancer and hyperfractionated accelerated radiotherapy (HART) with and without surgery.
    Jacobsen AB; Grøholt KK; Lorntzsen B; Osnes TA; Falk RS; Sigstad E
    Eur Arch Otorhinolaryngol; 2017 Dec; 274(12):4203-4209. PubMed ID: 29019001
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Marginal treatment benefit in anaplastic thyroid cancer.
    Haymart MR; Banerjee M; Yin H; Worden F; Griggs JJ
    Cancer; 2013 Sep; 119(17):3133-9. PubMed ID: 23839797
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of surgery to the primary tumor in metastatic anaplastic thyroid carcinoma: pooled analysis and SEER-based study.
    Oliinyk D; Augustin T; Rauch J; Koehler VF; Belka C; Spitzweg C; Käsmann L
    J Cancer Res Clin Oncol; 2023 Jul; 149(7):3527-3547. PubMed ID: 35960373
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multimodal treatments and outcomes for anaplastic thyroid cancer before and after tyrosine kinase inhibitor therapy: a real-world experience.
    Park J; Jung HA; Shim JH; Park WY; Kim TH; Lee SH; Kim SW; Ahn MJ; Park K; Chung JH
    Eur J Endocrinol; 2021 May; 184(6):837-845. PubMed ID: 33852431
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic factors and treatment outcomes of 100 cases of anaplastic thyroid carcinoma.
    Akaishi J; Sugino K; Kitagawa W; Nagahama M; Kameyama K; Shimizu K; Ito K; Ito K
    Thyroid; 2011 Nov; 21(11):1183-9. PubMed ID: 21936674
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk Factors Associated With Recurrence and Death in Patients With Tall Cell Papillary Thyroid Cancer: A Single-Institution Cohort Study With Predictive Nomogram.
    Wu SS; Joshi N; Sharrett J; Rao S; Shah A; Scharpf J; Burkey B; Lamarre ED; Prendes B; Siperstein A; Shin J; Berber E; Jin J; Krishnamurthi V; Nasr C; Hong L; Buchberger DS; Woody N; Koyfman SA; Geiger JL
    JAMA Otolaryngol Head Neck Surg; 2023 Jan; 149(1):79-86. PubMed ID: 36454559
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical characteristics and prognosis of anaplastic thyroid carcinoma: a 20-year single-center retrospective study].
    Wei YC; Zhang D; Chai Y; Dong M
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2023 Mar; 58(3):218-224. PubMed ID: 36878500
    [No Abstract]   [Full Text] [Related]  

  • 39. Expression of PD-1 and PD-L1 in Anaplastic Thyroid Cancer Patients Treated With Multimodal Therapy: Results From a Retrospective Study.
    Chintakuntlawar AV; Rumilla KM; Smith CY; Jenkins SM; Foote RL; Kasperbauer JL; Morris JC; Ryder M; Alsidawi S; Hilger C; Bible KC
    J Clin Endocrinol Metab; 2017 Jun; 102(6):1943-1950. PubMed ID: 28324060
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Real-World Experience with Targeted Therapy for the Treatment of Anaplastic Thyroid Carcinoma.
    Iyer PC; Dadu R; Ferrarotto R; Busaidy NL; Habra MA; Zafereo M; Gross N; Hess KR; Gule-Monroe M; Williams MD; Cabanillas ME
    Thyroid; 2018 Jan; 28(1):79-87. PubMed ID: 29161986
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.